SRI33576 was previously found to inhibit Wnt/β-catenin signaling in colorectal cancer cells by decreasing cytosolic axin2 and β-catenin and overall c-myc, survivin and cyclin D1 levels [40]. This evidence concerns the gene AXIN2 and colorectal cancer.